Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy

[Image: see text] The evaluation of new tuberculosis (TB) therapies is limited by the paucity of biomarkers to monitor treatment response. Previous work detected an uncharacterized urine metabolite with a molecular mass of 874.3547 Da that showed promise as a biomarker for successful TB treatment. U...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzgerald, Bryna L., Islam, M. Nurul, Graham, Barbara, Mahapatra, Sebabrata, Webb, Kristofor, Boom, W. Henry, Malherbe, Stephanus T., Joloba, Moses L., Johnson, John L., Winter, Jill, Walzl, Gerhard, Belisle, John T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412501/
https://www.ncbi.nlm.nih.gov/pubmed/30585483
http://dx.doi.org/10.1021/acsinfecdis.8b00241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412501/
https://www.ncbi.nlm.nih.gov/pubmed/30585483
http://dx.doi.org/10.1021/acsinfecdis.8b00241

Ejemplares similares